Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.7 |
mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | AZD-7545 | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |
mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | crizotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | -0.023 | 0.7 |
mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.041 | 0.7 |
mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | -0.024 | 0.7 |
mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | 0.016 | 0.7 |